Concepts (287)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Faculty, Medical | 10 | 2022 | 1181 | 1.440 |
Why?
|
Teaching | 8 | 2018 | 1174 | 1.200 |
Why?
|
Pulmonary Medicine | 4 | 2015 | 213 | 1.140 |
Why?
|
Education, Medical, Undergraduate | 6 | 2017 | 1008 | 0.890 |
Why?
|
Solitary Pulmonary Nodule | 2 | 2014 | 266 | 0.640 |
Why?
|
Schools, Medical | 4 | 2022 | 880 | 0.630 |
Why?
|
Education, Medical | 4 | 2018 | 1721 | 0.600 |
Why?
|
Curriculum | 5 | 2017 | 3605 | 0.600 |
Why?
|
Oxygen Inhalation Therapy | 2 | 2012 | 367 | 0.490 |
Why?
|
Students, Medical | 5 | 2017 | 1862 | 0.470 |
Why?
|
Peer Review | 1 | 2016 | 209 | 0.460 |
Why?
|
Carotid Artery, Common | 1 | 2014 | 183 | 0.440 |
Why?
|
Zygomycosis | 1 | 2012 | 7 | 0.430 |
Why?
|
Anesthesia, Local | 1 | 2014 | 275 | 0.400 |
Why?
|
Intergenerational Relations | 1 | 2012 | 68 | 0.400 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2014 | 1536 | 0.400 |
Why?
|
Lung Diseases, Fungal | 1 | 2012 | 122 | 0.390 |
Why?
|
Educational Measurement | 3 | 2017 | 1210 | 0.390 |
Why?
|
Inservice Training | 1 | 2013 | 392 | 0.380 |
Why?
|
Career Choice | 2 | 2014 | 744 | 0.380 |
Why?
|
Aneurysm, Infected | 1 | 2010 | 85 | 0.350 |
Why?
|
Aortic Valve Stenosis | 2 | 2014 | 1965 | 0.350 |
Why?
|
Self-Assessment | 1 | 2012 | 390 | 0.350 |
Why?
|
Risk Management | 1 | 2013 | 571 | 0.350 |
Why?
|
Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2009 | 42 | 0.340 |
Why?
|
Awareness | 1 | 2013 | 640 | 0.340 |
Why?
|
Pathology, Clinical | 1 | 2012 | 368 | 0.330 |
Why?
|
Clinical Clerkship | 2 | 2012 | 532 | 0.320 |
Why?
|
Problem-Based Learning | 1 | 2012 | 361 | 0.320 |
Why?
|
Program Evaluation | 2 | 2016 | 2488 | 0.300 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 5 | 2014 | 3047 | 0.300 |
Why?
|
Aneurysm, False | 1 | 2010 | 276 | 0.300 |
Why?
|
Reimbursement Mechanisms | 1 | 2013 | 670 | 0.300 |
Why?
|
Nerve Block | 1 | 2014 | 644 | 0.300 |
Why?
|
Aortic Rupture | 1 | 2010 | 310 | 0.300 |
Why?
|
Hospital Costs | 1 | 2013 | 985 | 0.290 |
Why?
|
Respiratory Paralysis | 1 | 2007 | 31 | 0.290 |
Why?
|
Thalidomide | 1 | 2012 | 890 | 0.280 |
Why?
|
Aortic Aneurysm | 1 | 2010 | 643 | 0.260 |
Why?
|
Oxygen Consumption | 1 | 2012 | 1869 | 0.260 |
Why?
|
Medicine | 1 | 2013 | 946 | 0.250 |
Why?
|
Guideline Adherence | 2 | 2014 | 2266 | 0.230 |
Why?
|
Aortic Valve | 1 | 2014 | 1922 | 0.230 |
Why?
|
Tomography, X-Ray Computed | 12 | 2014 | 20129 | 0.230 |
Why?
|
Bronchiolitis Obliterans | 1 | 2004 | 192 | 0.230 |
Why?
|
Staff Development | 3 | 2018 | 223 | 0.230 |
Why?
|
Population Surveillance | 1 | 2014 | 2616 | 0.220 |
Why?
|
Myelodysplastic Syndromes | 1 | 2012 | 1352 | 0.200 |
Why?
|
Societies, Medical | 1 | 2014 | 3743 | 0.200 |
Why?
|
Lung Transplantation | 3 | 2006 | 1153 | 0.200 |
Why?
|
Bariatric Surgery | 1 | 2011 | 952 | 0.190 |
Why?
|
Aortography | 2 | 2014 | 437 | 0.180 |
Why?
|
Warfarin | 1 | 2008 | 1496 | 0.180 |
Why?
|
Intensive Care Units | 1 | 2013 | 3679 | 0.180 |
Why?
|
Lung Diseases | 1 | 2009 | 1886 | 0.170 |
Why?
|
Tai Ji | 2 | 2014 | 285 | 0.170 |
Why?
|
Cardiac Output | 1 | 2001 | 854 | 0.170 |
Why?
|
Dyspnea | 1 | 2007 | 1303 | 0.170 |
Why?
|
Vascular Resistance | 1 | 2001 | 936 | 0.160 |
Why?
|
Learning | 3 | 2022 | 1713 | 0.160 |
Why?
|
Ambulatory Care | 1 | 2009 | 2708 | 0.160 |
Why?
|
Decision Support Techniques | 1 | 2008 | 1956 | 0.160 |
Why?
|
Physicians | 2 | 2013 | 4567 | 0.160 |
Why?
|
Clinical Protocols | 2 | 2014 | 1462 | 0.160 |
Why?
|
Pulmonary Embolism | 2 | 2008 | 2376 | 0.160 |
Why?
|
Academic Medical Centers | 3 | 2014 | 2759 | 0.150 |
Why?
|
Attitude of Health Personnel | 1 | 2011 | 3843 | 0.140 |
Why?
|
Emphysema | 2 | 2012 | 247 | 0.140 |
Why?
|
Spirometry | 2 | 2012 | 864 | 0.140 |
Why?
|
Fatal Outcome | 2 | 2012 | 1850 | 0.140 |
Why?
|
Group Processes | 1 | 2017 | 225 | 0.140 |
Why?
|
Respiratory Function Tests | 4 | 2012 | 1616 | 0.140 |
Why?
|
Foramen Ovale, Patent | 1 | 2018 | 223 | 0.130 |
Why?
|
Feedback | 2 | 2016 | 795 | 0.120 |
Why?
|
Humans | 44 | 2022 | 744343 | 0.120 |
Why?
|
Birt-Hogg-Dube Syndrome | 1 | 2014 | 39 | 0.120 |
Why?
|
Pneumonectomy | 2 | 2012 | 1094 | 0.120 |
Why?
|
Anticoagulants | 1 | 2008 | 4599 | 0.110 |
Why?
|
Sleep Medicine Specialty | 1 | 2014 | 71 | 0.110 |
Why?
|
Tracheomalacia | 1 | 2013 | 63 | 0.110 |
Why?
|
Pilot Projects | 4 | 2016 | 8324 | 0.110 |
Why?
|
Communication | 2 | 2018 | 3749 | 0.110 |
Why?
|
Interprofessional Relations | 1 | 2018 | 1011 | 0.110 |
Why?
|
Tracheal Diseases | 1 | 2012 | 113 | 0.100 |
Why?
|
Peer Review, Health Care | 1 | 2012 | 75 | 0.100 |
Why?
|
Telecommunications | 1 | 2012 | 80 | 0.100 |
Why?
|
Cardiovascular Agents | 1 | 2018 | 850 | 0.100 |
Why?
|
Critical Care | 2 | 2015 | 2647 | 0.100 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2013 | 214 | 0.100 |
Why?
|
Secondary Prevention | 1 | 2018 | 1530 | 0.100 |
Why?
|
Graft Rejection | 1 | 2004 | 4397 | 0.100 |
Why?
|
Mind-Body Therapies | 1 | 2014 | 247 | 0.100 |
Why?
|
Lung Neoplasms | 2 | 2014 | 13102 | 0.100 |
Why?
|
Cost Control | 1 | 2013 | 624 | 0.100 |
Why?
|
Hypertension, Pulmonary | 1 | 2001 | 1537 | 0.090 |
Why?
|
Pneumothorax | 1 | 2014 | 379 | 0.090 |
Why?
|
Sepsis | 2 | 2018 | 2593 | 0.090 |
Why?
|
Oximetry | 1 | 2014 | 471 | 0.090 |
Why?
|
Bupivacaine | 1 | 2014 | 411 | 0.090 |
Why?
|
Staphylococcus epidermidis | 1 | 2010 | 117 | 0.090 |
Why?
|
Severity of Illness Index | 4 | 2014 | 15540 | 0.090 |
Why?
|
Catheterization, Central Venous | 1 | 2015 | 514 | 0.090 |
Why?
|
Trachea | 2 | 2013 | 1076 | 0.090 |
Why?
|
Male | 24 | 2018 | 350118 | 0.090 |
Why?
|
Pulmonary Ventilation | 1 | 2012 | 373 | 0.090 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2013 | 501 | 0.090 |
Why?
|
Tidal Volume | 1 | 2012 | 490 | 0.090 |
Why?
|
Exercise Tolerance | 2 | 2012 | 770 | 0.090 |
Why?
|
Hospital Departments | 1 | 2009 | 137 | 0.090 |
Why?
|
Musculoskeletal Physiological Phenomena | 1 | 2009 | 30 | 0.080 |
Why?
|
Aged | 16 | 2018 | 163280 | 0.080 |
Why?
|
Incidental Findings | 1 | 2014 | 689 | 0.080 |
Why?
|
Boston | 2 | 2012 | 9313 | 0.080 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13695 | 0.080 |
Why?
|
Drugs, Generic | 1 | 2013 | 421 | 0.080 |
Why?
|
Obesity | 1 | 2011 | 12745 | 0.080 |
Why?
|
Fee-for-Service Plans | 1 | 2013 | 694 | 0.080 |
Why?
|
Patient Care Planning | 1 | 1993 | 921 | 0.080 |
Why?
|
Multiple Organ Failure | 1 | 2010 | 390 | 0.080 |
Why?
|
Bronchial Diseases | 2 | 2006 | 151 | 0.080 |
Why?
|
Exercise Test | 2 | 2012 | 2074 | 0.070 |
Why?
|
Magnetic Resonance Angiography | 1 | 2014 | 1442 | 0.070 |
Why?
|
Phrenic Nerve | 1 | 2007 | 79 | 0.070 |
Why?
|
Blood Transfusion | 1 | 2013 | 1301 | 0.070 |
Why?
|
Anesthetics, Local | 1 | 2014 | 985 | 0.070 |
Why?
|
Hospitals, Teaching | 1 | 2012 | 1179 | 0.070 |
Why?
|
Musculoskeletal System | 1 | 2009 | 175 | 0.070 |
Why?
|
Social Environment | 1 | 2012 | 1023 | 0.070 |
Why?
|
Immunocompromised Host | 1 | 2012 | 847 | 0.070 |
Why?
|
Radiography, Interventional | 1 | 2014 | 1095 | 0.070 |
Why?
|
Cross-Over Studies | 1 | 2012 | 2029 | 0.070 |
Why?
|
Pleural Effusion | 1 | 2009 | 338 | 0.070 |
Why?
|
Phosphates | 1 | 1990 | 786 | 0.070 |
Why?
|
Oxygen | 2 | 2012 | 4189 | 0.070 |
Why?
|
Documentation | 1 | 2012 | 871 | 0.070 |
Why?
|
Piperidines | 1 | 2014 | 1602 | 0.070 |
Why?
|
Echocardiography | 1 | 2018 | 5102 | 0.070 |
Why?
|
Hematoma | 1 | 2010 | 758 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2014 | 12959 | 0.060 |
Why?
|
Kidney Calculi | 1 | 1990 | 465 | 0.060 |
Why?
|
Bronchiectasis | 1 | 2006 | 128 | 0.060 |
Why?
|
Heart Valve Prosthesis | 1 | 2014 | 1488 | 0.060 |
Why?
|
Rare Diseases | 1 | 2009 | 553 | 0.060 |
Why?
|
Risk Assessment | 3 | 2012 | 23338 | 0.060 |
Why?
|
Female | 19 | 2018 | 380194 | 0.060 |
Why?
|
Income | 1 | 2013 | 1913 | 0.060 |
Why?
|
Perioperative Care | 1 | 2012 | 1002 | 0.060 |
Why?
|
Biopsy, Needle | 1 | 2009 | 1641 | 0.060 |
Why?
|
Cysts | 1 | 2009 | 678 | 0.060 |
Why?
|
Echocardiography, Transesophageal | 1 | 2010 | 1133 | 0.060 |
Why?
|
Medical Records | 1 | 2009 | 1413 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2014 | 2849 | 0.060 |
Why?
|
Drainage | 1 | 2009 | 1142 | 0.060 |
Why?
|
Hemangioma, Capillary | 1 | 2003 | 61 | 0.060 |
Why?
|
Middle Aged | 14 | 2018 | 213383 | 0.060 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2013 | 1209 | 0.060 |
Why?
|
Radiography, Thoracic | 1 | 2009 | 1265 | 0.050 |
Why?
|
Health Care Costs | 2 | 2013 | 3209 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2018 | 19905 | 0.050 |
Why?
|
Posture | 1 | 2007 | 958 | 0.050 |
Why?
|
Recurrence | 2 | 2018 | 8340 | 0.050 |
Why?
|
Obesity, Morbid | 1 | 2013 | 1213 | 0.050 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 2002 | 116 | 0.050 |
Why?
|
Living Donors | 1 | 2006 | 620 | 0.050 |
Why?
|
Doxycycline | 1 | 2003 | 326 | 0.050 |
Why?
|
Bronchi | 1 | 2006 | 840 | 0.050 |
Why?
|
Life Expectancy | 1 | 2008 | 1184 | 0.050 |
Why?
|
Patient Care Team | 1 | 2013 | 2531 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4554 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2018 | 57776 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2018 | 77449 | 0.050 |
Why?
|
Massachusetts | 2 | 2012 | 8663 | 0.050 |
Why?
|
Osteoporosis | 1 | 2011 | 1580 | 0.050 |
Why?
|
Internship and Residency | 2 | 2013 | 5788 | 0.050 |
Why?
|
Radiographic Image Enhancement | 1 | 2006 | 885 | 0.050 |
Why?
|
Accidental Falls | 1 | 2008 | 1062 | 0.050 |
Why?
|
Self Report | 1 | 2012 | 3558 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2011 | 2278 | 0.050 |
Why?
|
Health Expenditures | 1 | 2013 | 2348 | 0.050 |
Why?
|
Data Collection | 1 | 2009 | 3341 | 0.040 |
Why?
|
Physician-Patient Relations | 1 | 1993 | 3229 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2018 | 13989 | 0.040 |
Why?
|
Orthopedics | 1 | 2009 | 904 | 0.040 |
Why?
|
Sarcoidosis | 1 | 2005 | 506 | 0.040 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2006 | 1184 | 0.040 |
Why?
|
United States | 3 | 2017 | 69872 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2018 | 63114 | 0.040 |
Why?
|
Age Factors | 2 | 2012 | 18370 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15076 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2012 | 12026 | 0.040 |
Why?
|
Analgesics, Opioid | 1 | 2014 | 3674 | 0.040 |
Why?
|
Vasodilation | 1 | 2001 | 944 | 0.040 |
Why?
|
Septal Occluder Device | 1 | 2018 | 128 | 0.040 |
Why?
|
Pulmonary Emphysema | 1 | 2002 | 672 | 0.040 |
Why?
|
Mentors | 1 | 2022 | 631 | 0.040 |
Why?
|
Calcium | 1 | 1990 | 5756 | 0.040 |
Why?
|
Lung | 2 | 2006 | 9856 | 0.030 |
Why?
|
Adult | 11 | 2018 | 214055 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2009 | 11366 | 0.030 |
Why?
|
Stroke | 1 | 2018 | 9981 | 0.030 |
Why?
|
Tissue Donors | 1 | 2004 | 2240 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2013 | 5319 | 0.030 |
Why?
|
Breathing Exercises | 1 | 2014 | 53 | 0.030 |
Why?
|
Kidney | 1 | 1990 | 7186 | 0.030 |
Why?
|
Acute Disease | 1 | 2004 | 7149 | 0.030 |
Why?
|
Granulomatous Disease, Chronic | 1 | 1995 | 174 | 0.030 |
Why?
|
Peer Group | 1 | 2018 | 635 | 0.030 |
Why?
|
Forced Expiratory Volume | 2 | 2010 | 1743 | 0.030 |
Why?
|
Ultrasonography | 1 | 2007 | 5985 | 0.030 |
Why?
|
Time Factors | 2 | 2018 | 40075 | 0.030 |
Why?
|
Angiogenesis Inhibitors | 1 | 2003 | 2038 | 0.030 |
Why?
|
Manikins | 1 | 2015 | 238 | 0.030 |
Why?
|
Health Status | 1 | 2006 | 4034 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2001 | 1912 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 17446 | 0.030 |
Why?
|
Professional Autonomy | 1 | 2013 | 177 | 0.030 |
Why?
|
Mental Health | 1 | 2006 | 3019 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2011 | 39050 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 7181 | 0.030 |
Why?
|
Models, Educational | 1 | 2015 | 377 | 0.030 |
Why?
|
Prosthesis Design | 1 | 2018 | 2110 | 0.020 |
Why?
|
Professional Practice | 1 | 1993 | 326 | 0.020 |
Why?
|
Hemodynamics | 1 | 2001 | 4199 | 0.020 |
Why?
|
Sleep | 1 | 2007 | 4623 | 0.020 |
Why?
|
Models, Anatomic | 1 | 2015 | 691 | 0.020 |
Why?
|
Sex Factors | 1 | 2004 | 10397 | 0.020 |
Why?
|
Survival Rate | 1 | 2004 | 12788 | 0.020 |
Why?
|
Absorption | 1 | 1990 | 248 | 0.020 |
Why?
|
Mutation | 1 | 2014 | 29786 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2012 | 1681 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 1995 | 1000 | 0.020 |
Why?
|
Nephrons | 1 | 1990 | 220 | 0.020 |
Why?
|
Prospective Studies | 3 | 2022 | 53288 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2009 | 15295 | 0.020 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2006 | 88 | 0.020 |
Why?
|
Total Lung Capacity | 1 | 2006 | 143 | 0.020 |
Why?
|
Pedigree | 1 | 2014 | 4644 | 0.020 |
Why?
|
Fellowships and Scholarships | 1 | 2015 | 1076 | 0.020 |
Why?
|
Fatigue | 1 | 2013 | 1531 | 0.020 |
Why?
|
Interferon-gamma | 1 | 1995 | 3206 | 0.020 |
Why?
|
Blood Pressure | 1 | 2001 | 8554 | 0.020 |
Why?
|
Observer Variation | 1 | 2012 | 2593 | 0.020 |
Why?
|
Algorithms | 1 | 2006 | 13881 | 0.020 |
Why?
|
Walking | 1 | 2012 | 1180 | 0.020 |
Why?
|
Organizational Innovation | 1 | 2008 | 559 | 0.020 |
Why?
|
Exhalation | 1 | 2005 | 167 | 0.020 |
Why?
|
Patient Participation | 1 | 1993 | 1457 | 0.010 |
Why?
|
Physical Endurance | 1 | 2006 | 370 | 0.010 |
Why?
|
Vital Capacity | 1 | 2006 | 925 | 0.010 |
Why?
|
Tissue and Organ Harvesting | 1 | 2006 | 369 | 0.010 |
Why?
|
Parathyroid Hormone | 1 | 1990 | 1801 | 0.010 |
Why?
|
Risk Factors | 3 | 2018 | 72290 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7729 | 0.010 |
Why?
|
Consensus | 1 | 2012 | 2959 | 0.010 |
Why?
|
Emotions | 1 | 2014 | 2661 | 0.010 |
Why?
|
Isotopes | 1 | 2002 | 124 | 0.010 |
Why?
|
Helium | 1 | 2002 | 123 | 0.010 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2003 | 599 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 9959 | 0.010 |
Why?
|
Endothelium | 1 | 2003 | 778 | 0.010 |
Why?
|
Quality of Life | 2 | 2014 | 12804 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2006 | 2373 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2006 | 2539 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2005 | 3508 | 0.010 |
Why?
|
Adolescent | 2 | 2004 | 85781 | 0.010 |
Why?
|
Patient-Centered Care | 1 | 2008 | 1439 | 0.010 |
Why?
|
Prevalence | 1 | 2012 | 15226 | 0.010 |
Why?
|
Body Mass Index | 1 | 2013 | 12720 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 21746 | 0.010 |
Why?
|
Infant | 2 | 1995 | 35136 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2002 | 35421 | 0.010 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 1995 | 93 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2006 | 3396 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 3923 | 0.010 |
Why?
|
Phagocytes | 1 | 1995 | 297 | 0.010 |
Why?
|
Diet | 1 | 1990 | 7939 | 0.010 |
Why?
|
Thyrotropin | 1 | 1995 | 849 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14722 | 0.010 |
Why?
|
Safety | 1 | 1995 | 1186 | 0.010 |
Why?
|
Growth Disorders | 1 | 1995 | 645 | 0.010 |
Why?
|
Neutropenia | 1 | 1995 | 895 | 0.010 |
Why?
|
Fever | 1 | 1995 | 1616 | 0.000 |
Why?
|
Prognosis | 1 | 2006 | 29063 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1995 | 6622 | 0.000 |
Why?
|
Incidence | 1 | 1995 | 20947 | 0.000 |
Why?
|
Child, Preschool | 1 | 1995 | 41006 | 0.000 |
Why?
|
Child | 1 | 1995 | 77709 | 0.000 |
Why?
|
Concepts
(287)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(49)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_